400 related articles for article (PubMed ID: 31754156)
1. Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicles.
Do MA; Levy D; Brown A; Marriott G; Lu B
Sci Rep; 2019 Nov; 9(1):17274. PubMed ID: 31754156
[TBL] [Abstract][Full Text] [Related]
2. Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders.
Lu B; Ku J; Flojo R; Olson C; Bengford D; Marriott G
Adv Drug Deliv Rev; 2022 Sep; 188():114465. PubMed ID: 35878794
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
[TBL] [Abstract][Full Text] [Related]
4. Recapture Lysosomal Enzyme Deficiency via Targeted Gene Disruption in the Human Near-Haploid Cell Line HAP1.
Brown A; Zhang J; Lawler B; Lu B
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356092
[TBL] [Abstract][Full Text] [Related]
5. Altered level of plasma exosomes in patients with Gaucher disease.
Tatiana S; Stanislav N; Darya K; Luiza G; Konstantin S; Sergey L; Elena V; Galina S; Nikolai V; Arthur K; Elena Z; Roman K; Tatiana U; Alexander S; Ekaterina Z; Anton E; Sofya P
Eur J Med Genet; 2020 Nov; 63(11):104038. PubMed ID: 32822875
[TBL] [Abstract][Full Text] [Related]
6. Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, β-glucocerebrosidase.
Jović M; Kean MJ; Szentpetery Z; Polevoy G; Gingras AC; Brill JA; Balla T
Mol Biol Cell; 2012 Apr; 23(8):1533-45. PubMed ID: 22337770
[TBL] [Abstract][Full Text] [Related]
7. Pseudotyping exosomes for enhanced protein delivery in mammalian cells.
Meyer C; Losacco J; Stickney Z; Li L; Marriott G; Lu B
Int J Nanomedicine; 2017; 12():3153-3170. PubMed ID: 28458537
[TBL] [Abstract][Full Text] [Related]
8. Membrane-bound extracellular vesicles secreted by parasitic protozoa: cellular structures involved in the communication between cells.
de Souza W; Barrias ES
Parasitol Res; 2020 Jul; 119(7):2005-2023. PubMed ID: 32394001
[TBL] [Abstract][Full Text] [Related]
9. The Role of Exosomes in Lysosomal Storage Disorders.
Gleason AM; Woo EG; McKinney C; Sidransky E
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33920837
[TBL] [Abstract][Full Text] [Related]
10. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
[TBL] [Abstract][Full Text] [Related]
11. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
[TBL] [Abstract][Full Text] [Related]
13. Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders.
Tancini B; Buratta S; Sagini K; Costanzi E; Delo F; Urbanelli L; Emiliani C
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31284546
[TBL] [Abstract][Full Text] [Related]
14. Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake.
Zhang J; Brown A; Johnson B; Diebold D; Asano K; Marriott G; Lu B
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559058
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
[TBL] [Abstract][Full Text] [Related]
16. Genetic labeling of extracellular vesicles for studying biogenesis and uptake in living mammalian cells.
Levy D; Do MA; Brown A; Asano K; Diebold D; Chen H; Zhang J; Lawler B; Lu B
Methods Enzymol; 2020; 645():1-14. PubMed ID: 33565965
[TBL] [Abstract][Full Text] [Related]
17. Drug-Induced Lysosomal Impairment Is Associated with the Release of Extracellular Vesicles Carrying Autophagy Markers.
Sagini K; Buratta S; Delo F; Pellegrino RM; Giovagnoli S; Urbanelli L; Emiliani C
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884727
[TBL] [Abstract][Full Text] [Related]
18. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E
J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851
[TBL] [Abstract][Full Text] [Related]
19. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
20. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
Ingato D; Lee JU; Sim SJ; Kwon YJ
J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
